Jeffrey Burris - INDIVIOR PLC Chief Officer
| INVVYDelisted Stock | USD 21.85 0.20 0.92% |
Insider
Jeffrey Burris is Chief Officer of INDIVIOR PLC ADR
| Age | 51 |
| Phone | 804 379 1090 |
| Web | https://www.indivior.com |
INDIVIOR PLC Management Efficiency
The company has return on total asset (ROA) of 0.0697 % which means that it generated a profit of $0.0697 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.8557 %, meaning that it generated $0.8557 on every $100 dollars invested by stockholders. INDIVIOR PLC's management efficiency ratios could be used to measure how well INDIVIOR PLC manages its routine affairs as well as how well it operates its assets and liabilities.INDIVIOR PLC ADR has accumulated 239 M in total debt with debt to equity ratio (D/E) of 1.22, which is about average as compared to similar companies. INDIVIOR PLC ADR has a current ratio of 1.67, which is within standard range for the sector. Debt can assist INDIVIOR PLC until it has trouble settling it off, either with new capital or with free cash flow. So, INDIVIOR PLC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like INDIVIOR PLC ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for INDIVIOR to invest in growth at high rates of return. When we think about INDIVIOR PLC's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Thomas Harvey | Alkermes Plc | N/A | |
| Shawn McKee | Elanco Animal Health | N/A | |
| Joyce Lee | Elanco Animal Health | 47 | |
| Scott Sudduth | Collegium Pharmaceutical | N/A | |
| Keith Lavan | Petros Pharmaceuticals | 60 | |
| Albert Bolles | Lifecore Biomedical | 66 | |
| Robert Weinstein | Petros Pharmaceuticals | 64 | |
| Karen Flynn | Catalent | 56 | |
| Ricci Whitlow | Catalent | 51 | |
| Fredrik Jarrsten | Orexo AB | 56 | |
| David Francisco | Organogenesis Holdings | 58 | |
| Jude Onyia | Neurocrine Biosciences | 60 | |
| MD FACC | Esperion Therapeutics | 59 | |
| Luiz Clavis | Hypera SA | N/A | |
| Kurt Matheson | Organogenesis Holdings | N/A | |
| Zorina Pitkin | Organogenesis Holdings | N/A | |
| R Hoover | Elanco Animal Health | 75 | |
| Dennis Urbaniak | Orexo AB | 54 | |
| Matthew Lowell | Alpha Teknova | 54 | |
| Mauricio Christovam | Hypera SA | N/A | |
| Richard MD | Collegium Pharmaceutical | 64 | |
Management Performance
| Return On Equity | 0.86 | |||
| Return On Asset | 0.0697 |
INDIVIOR PLC ADR Leadership Team
Elected by the shareholders, the INDIVIOR PLC's board of directors comprises two types of representatives: INDIVIOR PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of INDIVIOR. The board's role is to monitor INDIVIOR PLC's management team and ensure that shareholders' interests are well served. INDIVIOR PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, INDIVIOR PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jon Fogle, Chief Human Resource Officer | ||
| Nina DeLorenzo, Chief Officer | ||
| Jeffrey Burris, Chief Officer | ||
| Jason Thompson, VP Relations | ||
| Christian Heidbreder, Chief Scientific Officer | ||
| Richard Simkin, Chief Commercial and Strategy Officer | ||
| Ryan Preblick, CFO Director | ||
| Mark Crossley, CFO, Director | ||
| Hillel West, Chief Officer | ||
| Cynthia Cetani, Chief Officer |
INDIVIOR Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is INDIVIOR PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.86 | |||
| Return On Asset | 0.0697 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 2.39 B | |||
| Shares Outstanding | 136.19 M | |||
| Shares Owned By Institutions | 0.30 % | |||
| Price To Earning | 37.60 X | |||
| Price To Book | 13.75 X | |||
| Price To Sales | 3.47 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in INDIVIOR Pink Sheet
If you are still planning to invest in INDIVIOR PLC ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INDIVIOR PLC's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |